RPR-22239-24286
3 vaccinations
4 coded responses
22 check-ins
2 free-text entries
2 call cases
- Sex
- Male
- Age at first dose
- 0-4
- ZIP prefix
- 220 / VA
- Registered
- 2022-10-07
- Relationship
- Child or adolescent in my care
- Guardian
- H7V-34511-51923
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-10-05
Dose 1 — Moderna
-
2022-10-07
Registered in v-safe
- 2022-10-07
- 2022-10-08
- 2022-10-09
- 2022-10-10
- 2022-10-11
- 2022-10-14
- 2022-10-19
- 2022-10-26
- 2022-11-02
-
2022-11-04
Dose 2 — Moderna
-
2022-11-05
Health check-in — days 1–6 daily, dose 2, under 3Feeling: Fair · Site: Redness, Swelling/hardness · Fever · Sleepiness, Irritability/crying · Be unable to do your normal daily activitiesUnder 3 check-in
-
2022-11-06
Health check-in — days 1–6 daily, dose 2, under 3Feeling: Good · Site: Redness · NoneUnder 3 check-in
- 2022-11-07
- 2022-11-08
- 2022-11-10
- 2022-11-11
-
2022-11-18
Survey response — day 14, dose 2, under 3MedDRA: Respiratory tract congestion — Feeling: GoodFree text: CongestedMedDRA releases: 2024-11 · check-in free text available
-
2022-11-25
Survey response — day 21, dose 2, under 3MedDRA: Cough, Nasopharyngitis, Respiratory tract congestion — Feeling: FairFree text: Cold with congestion and coughMedDRA releases: 2024-11 · check-in free text available
- 2022-12-02
- 2022-12-09
- 2022-12-16
-
2023-01-09
Dose 3 — Moderna
-
2023-02-03
Survey response — 3 months, dose 2, under 3MedDRA: Bronchial hyperreactivity, Bronchiolitis — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visitMedDRA releases: 2024-11
-
2023-02-03
Report sent to call center — 3 months, dose 2, under 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prEmergency room or emergency department visit · 1 call case(s)
-
2023-02-06
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2023-04-10
Survey response — 3 months, dose 3, under 3MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitMedDRA releases: 2024-11
-
2023-04-10
Report sent to call center — 3 months, dose 3, under 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2023-04-11
-
2023-04-11
Call successfulCompleted over the phone
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-10-05 | Moderna | No |
| 2 | 2022-11-04 | Moderna | No |
| 3 | 2023-01-09 | Moderna | No |
Call center
2 call center cases
2 successful
VAERS report filed, before or during a call: 1
Free text
Release 12 (Under 3) — day 14, dose 2, under 3
Symptoms: Congested
Release 12 (Under 3) — day 21, dose 2, under 3
Symptoms: Cold with congestion and cough
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Bronchial hyperreactivity | · | · | ✓ |
| SD | Bronchiolitis | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release